A detailed history of Goepper Burkhardt LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Goepper Burkhardt LLC holds 5,566 shares of JNJ stock, worth $882,544. This represents 0.41% of its overall portfolio holdings.

Number of Shares
5,566
Previous 6,076 8.39%
Holding current value
$882,544
Previous $952,000 7.56%
% of portfolio
0.41%
Previous 0.49%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$155.22 - $162.74 $79,162 - $82,997
-510 Reduced 8.39%
5,566 $880,000
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $186,076 - $203,048
-1,278 Reduced 17.38%
6,076 $952,000
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $10.1 Million - $11.3 Million
-64,896 Reduced 89.82%
7,354 $1.15 Million
Q2 2023

Aug 16, 2023

BUY
$154.35 - $166.11 $10 Million - $10.8 Million
64,927 Added 886.62%
72,250 $12 Million
Q1 2023

May 12, 2023

SELL
$151.05 - $180.26 $7,552 - $9,013
-50 Reduced 0.68%
7,323 $1.14 Million
Q4 2022

Feb 15, 2023

BUY
$160.2 - $179.79 $228,284 - $256,200
1,425 Added 23.96%
7,373 $1.3 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $16,133 - $17,952
100 Added 1.71%
5,948 $972,000
Q2 2022

Aug 26, 2022

BUY
$168.19 - $186.01 $33,133 - $36,643
197 Added 3.49%
5,848 $1.04 Million
Q1 2022

Apr 22, 2022

BUY
$158.14 - $179.59 $36,530 - $41,485
231 Added 4.26%
5,651 $1 Million
Q4 2021

Jan 21, 2022

BUY
$155.93 - $173.01 $5,769 - $6,401
37 Added 0.69%
5,420 $927,000
Q3 2021

Oct 28, 2021

SELL
$161.5 - $179.47 $32,300 - $35,894
-200 Reduced 3.58%
5,383 $869,000
Q2 2021

Jul 28, 2021

BUY
$159.48 - $171.07 $16,107 - $17,278
101 Added 1.84%
5,583 $920,000
Q1 2021

May 11, 2021

SELL
$153.07 - $170.48 $15,153 - $16,877
-99 Reduced 1.77%
5,482 $901,000
Q4 2020

Feb 08, 2021

BUY
$137.11 - $157.38 $765,210 - $878,337
5,581 New
5,581 $878,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $415B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Goepper Burkhardt LLC Portfolio

Follow Goepper Burkhardt LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goepper Burkhardt LLC, based on Form 13F filings with the SEC.

News

Stay updated on Goepper Burkhardt LLC with notifications on news.